A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

The US Department of Health and Human Services announced the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

Return on Assets (ROA): Neurocrine Biosciences's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.84%, the company showcases ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Good morning, Boston, and happy Friday. Here are the five things you need to know in local business news to start your busy day, including Moderna's cost cuts, "misunderstood" Wayfair, the highest ...

Health Secretary Robert F. Kennedy Jr. on Thursday announced plans to require all new vaccines to be tested against placebos ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...